GLP-1 weight loss, reviewed online in Philadelphia, Pennsylvania
Start online from Philadelphia. Online care for eligible Pennsylvania residents. Answer health questions, get reviewed by a licensed provider, and if treatment is medically appropriate, your prescription may be sent to a licensed pharmacy and shipped discreetly.
Private online review. Clear pricing. Ships discreetly if prescribed.
Treatment Options
GLP-1 Medications
Semaglutide and tirzepatide options, reviewed by a licensed provider to determine what may be right for you.
Provider Reviewed
Licensed evaluation
Treatment only if prescribed
Can I start online GLP-1 weight loss treatment in Philadelphia, Pennsylvania?
Yes. Residents of Philadelphia, Pennsylvania can begin an online GLP-1 weight-loss evaluation with Surfbound without an in-person visit. After you complete a short health intake, a licensed provider credentialed in Pennsylvania reviews your information and, if treatment is medically appropriate, your prescription may be sent to a licensed pharmacy and shipped discreetly to your Philadelphia address. Semaglutide is $169/mo and tirzepatide is $219/mo; a prescription is never guaranteed.
In short
- No office visit required — start online from anywhere in Philadelphia.
- Reviewed by a Pennsylvania-licensed provider; treatment is offered only when medically appropriate.
- Clear cash-pay pricing — semaglutide $169/mo, tirzepatide $219/mo — with discreet shipping if prescribed.
Why Philadelphia residents choose Surfbound: Skip the drive into Center City — reviewed from home.
Where is Philadelphia, Pennsylvania — and how does online treatment reach it?
Philadelphia is a dense Northeast city and one of the largest in the country.
Serving Philadelphia and nearby areas
What this means for Philadelphia residents
Because care is delivered online, you skip the commute, parking, and wait times that come with an in-person clinic. Your intake is reviewed by a licensed provider credentialed in Pennsylvania, and treatment is only offered when medically appropriate.
The Keystone State · Northeast region. Philadelphia and Pittsburgh metros plus a rural central region.
Provider review for Philadelphia, Pennsylvania
How licensed providers evaluate your health information for online GLP-1 treatment review in Pennsylvania.
How the review works
Pennsylvania residents are reviewed by providers licensed through the Pennsylvania State Board of Medicine. The online health intake is comprehensive, and providers review cases asynchronously. Pennsylvania’s mix of dense urban areas and rural communities makes Surfbound’s online model broadly applicable.
Submit your health questionnaire online from Philadelphia, Pittsburgh, Harrisburg, or anywhere in Pennsylvania.
A Pennsylvania-licensed provider reviews your medical information.
If treatment is medically appropriate, a prescription is sent to a licensed compounding pharmacy.
Medication ships discreetly to your Pennsylvania address.
What providers evaluate
Important: A prescription is not guaranteed. Treatment is offered only when a licensed provider determines it is medically appropriate based on your individual health profile. Providers are licensed to practice in Pennsylvania.
Pennsylvania permits telemedicine prescribing when a proper provider-patient relationship exists. The state enacted comprehensive telemedicine legislation in 2019 to support remote care delivery.
Shipping to Philadelphia, Pennsylvania
Discreet delivery timelines and shipping details for Pennsylvania residents.
Processing & shipping
We prioritize fast shipping after provider approval and pharmacy processing. Tracking is provided; timing varies by pharmacy, location, weekends and holidays.
Delivery estimate
We prioritize fast shipping after provider approval and pharmacy processing. Tracking is provided; timing varies by pharmacy, location, weekends and holidays.
Packaging & tracking
Prompt, temperature-controlled shipping with tracking.
What to expect with your shipment to Philadelphia
Discreet plain packaging — no branding visible on the outside
Temperature-controlled packaging when required
Email tracking number once pharmacy ships
Clear usage instructions included with medication
Delivery times are estimates and may vary based on pharmacy processing, carrier volume, weather, and your specific location within Pennsylvania. If prescribed, you will receive tracking information by email.
GLP-1 treatment options
Provider-reviewed options. A licensed provider determines which treatment, if any, may be medically appropriate.
Semaglutide at $169/month and tirzepatide at $219/month. No separate membership fee.
Semaglutide
A GLP-1 option reviewed by a licensed provider for eligible patients seeking medical weight-loss support.
Semaglutide detailsTirzepatide
A GLP-1 option that may be reviewed for eligible patients when medically appropriate.
Tirzepatide detailsHow online treatment works
From online intake to treatment at your door. Learn more about GLP-1 treatment
Complete your intake online
Answer questions about your health history, weight goals, medications, and basic eligibility.
Provider review
A licensed provider reviews your information and determines whether GLP-1 treatment is medically appropriate.
Ships if prescribed
If prescribed, your medication may be sent to a licensed pharmacy and shipped discreetly to your door.
What's included
One flat monthly price covers the licensed provider review, medication if prescribed, and discreet shipping. Prescription treatment is not guaranteed — a licensed provider determines whether treatment is medically appropriate based on your health information.
Frequently asked questions
Location-specific answers about starting treatment from Philadelphia and Pennsylvania.
No. Surfbound is an online service with no physical offices. Residents of Philadelphia and Philadelphia County can start online, and a licensed provider reviews their information remotely.
Surfbound serves the entire Pennsylvania region, including Center City, Fishtown, University City, Manayunk and surrounding communities. Because care is delivered online, your location within Philadelphia does not affect eligibility.
No. Surfbound is an online service. You can start from home, and a licensed provider reviews your information online.
After provider approval and pharmacy processing, medication typically ships promptly in temperature-controlled packaging. Many orders ship within approximately 1–2 days after pharmacy processing, although timing may vary by pharmacy, patient location, weekends, and holidays. Tracking is provided.
Yes. Licensed providers can legally review patient information and prescribe medication through telehealth in Pennsylvania when medically appropriate. Surfbound’s providers are licensed to practice in Pennsylvania.
You must be physically located in Pennsylvania at the time of your online provider review, as providers are licensed to practice in Pennsylvania. You do not need to be a permanent resident.
Lab requirements are determined by the licensed provider during your review. Some patients may be asked to provide recent lab results; others may not need labs based on their health history and the provider’s medical judgment.
Semaglutide is $169/mo and tirzepatide is $219/mo. Pricing is shown before checkout.
Surfbound does not accept insurance at this time.
Eligibility depends on your health history, BMI, medications, and provider review. A prescription is not guaranteed.
Both are GLP-1-based treatment options that may be reviewed by a licensed provider for eligible patients. A provider determines which option, if any, may be medically appropriate.
No. Prescription treatment is only offered when a licensed provider determines it is medically appropriate.
No. Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.
Medical sources & references
Surfbound providers are licensed to practice in Pennsylvania and follow applicable state medical board rules for telehealth. The following authoritative sources inform our treatment information.
- FDA — Human Drug CompoundingFDA guidance clarifying that compounded medications are not FDA-approved.
- FDA — Compounding: Questions and AnswersConfirms compounded drugs are not reviewed by FDA for safety or effectiveness.
- NIDDK (NIH) — Prescription Medications to Treat Overweight & ObesityNIH guidance on GLP-1 receptor agonists for medical weight management.
- CDC — Adult Obesity FactsNational adult obesity prevalence data referenced for regional context.
- ASMBS — American Society for Metabolic and Bariatric SurgeryProfessional guidance on metabolic and bariatric medicine.
- MedlinePlus (NIH) — Weight ControlConsumer health information on weight management from the National Library of Medicine.
Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed. A prescription is not guaranteed and is issued only when a licensed provider determines treatment is medically appropriate.
Pennsylvania telehealth & prescription information
Important regulatory and medical disclaimer information for Pennsylvania residents considering online GLP-1 treatment review.
Pennsylvania regulatory information
Pennsylvania telemedicine services comply with the Pennsylvania Medical Practice Act (Act 112 of 2019). Providers are licensed by the Pennsylvania State Board of Medicine or the State Board of Osteopathic Medicine. A prescription is not guaranteed. Compounded medications are prepared by state-licensed compounding pharmacies and are not independently evaluated or approved by the FDA.
Compounded medication notice
Compounded medications are customized preparations made by licensed pharmacies based on a provider’s prescription. They are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed. Compounded semaglutide and tirzepatide are not generic versions of brand-name medications and have not been evaluated by the FDA for equivalence to commercially available products.
Not a replacement for primary care
Surfbound’s online provider review is not a replacement for your primary care provider. We recommend maintaining a relationship with a local healthcare provider in Pennsylvania for comprehensive medical care, including regular check-ups, preventive screenings, and management of chronic conditions. Our providers focus specifically on evaluating eligibility for GLP-1 weight-loss treatment.
Important safety information
GLP-1 medications carry risks including gastrointestinal side effects, pancreatitis, gallbladder issues, and other potential adverse effects. Tell your provider about all health conditions and medications during your online intake. Do not use GLP-1 medications if you are pregnant, planning to become pregnant, or have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. If you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction, seek emergency medical care immediately.
Pennsylvania residents: By using Surfbound, you acknowledge that online treatment review involves providing health information electronically for evaluation by a licensed provider. You understand that a prescription is not guaranteed and is issued only when a provider determines that treatment is medically appropriate. You agree that Surfbound is not an emergency medical service and should not be used for urgent or emergency medical needs. If you are experiencing a medical emergency, call 911 or go to your nearest emergency room immediately.
Ready to start from Philadelphia?
Answer a few health questions online and get reviewed by a licensed provider.
Private online review. Ships discreetly if prescribed.